Holen Sie sich die Stockscreener-App
6.64
5.41%
-0.38
Handel nachbörslich:
6.55
-0.09
-1.36%
Schlusskurs vom Vortag:
$7.02
Offen:
$6.97
24-Stunden-Volumen:
381.27K
Relative Volume:
0.97
Marktkapitalisierung:
$343.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.90M
KGV:
-12.53
EPS:
-0.53
Netto-Cashflow:
$-19.80M
1W Leistung:
-6.08%
1M Leistung:
-6.87%
6M Leistung:
+89.17%
1J Leistung:
+50.23%
1-Tages-Spanne:
$6.56
$7.0367
1-Wochen-Bereich:
$6.56
$7.14
52-Wochen-Spanne:
$3.19
$7.4899
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
Firmenname
Diamedica Therapeutics Inc
Sektor
Branche
Telefon
(763) 496-5454
Adresse
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Vergleichen Sie DMAC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
6.64 | 362.86M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-06-22 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-04-09 | Eingeleitet | Oppenheimer | Outperform |
| 2021-02-17 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-30 | Eingeleitet | Guggenheim | Buy |
| 2020-07-08 | Eingeleitet | Maxim Group | Buy |
| 2019-04-30 | Eingeleitet | Dougherty & Company | Buy |
| 2019-03-05 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Diamedica Therapeutics Inc Aktie (DMAC) Neueste Nachrichten
How risky is DiaMedica Therapeutics Inc. stock nowJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Is DiaMedica Therapeutics Inc. stock bottoming outJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com
How hedge fund analytics apply to DiaMedica Therapeutics Inc. stockEarnings Summary Report & Real-Time Sentiment Analysis - newser.com
DiaMedica Therapeutics' (DMAC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Is it too late to sell DiaMedica Therapeutics Inc.July 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com
Can DiaMedica Therapeutics Inc. stock continue upward trendJuly 2025 Update & Low Drawdown Trading Techniques - newser.com
After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright - MSN
Is DiaMedica Therapeutics Inc a good long term investmentHealthcare Stock Analysis & Superior Capital Growth - earlytimes.in
DiaMedica Therapeutics (NASDAQ:DMAC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Will DiaMedica Therapeutics Inc. bounce back from current support2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
DiaMedica Therapeutics Inc. stock volume spike explainedRate Cut & Daily Profit Maximizing Trade Tips - newser.com
Published on: 2025-10-03 00:24:41 - newser.com
Published on: 2025-10-02 18:46:41 - newser.com
Perigon Wealth Management LLC Acquires Shares of 53,000 DiaMedica Therapeutics, Inc. $DMAC - MarketBeat
Tick level data insight on DiaMedica Therapeutics Inc. volatilityJuly 2025 News Drivers & Verified Swing Trading Watchlist - newser.com
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Published on: 2025-09-29 10:18:49 - newser.com
What analysts say about DiaMedica Therapeutics Inc stockContrarian Investment Ideas & Free Superior Stock Performance - Early Times
How DiaMedica Therapeutics Inc. stock reacts to oil prices2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
DiaMedica Therapeutics, Inc. $DMAC Shares Bought by Goldman Sachs Group Inc. - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Lowered to “Sell” Rating by Wall Street Zen - Defense World
DiaMedica Therapeutics (NASDAQ:DMAC) Downgraded by Wall Street Zen to Sell - MarketBeat
Best Momentum Stocks to Buy for October 14th - MSN
Using portfolio simulators with DiaMedica Therapeutics Inc. includedJuly 2025 Decliners & Long-Term Growth Plans - newser.com
Published on: 2025-09-22 10:09:38 - newser.com
Published on: 2025-09-22 04:11:25 - newser.com
Using Python tools to backtest DiaMedica Therapeutics Inc. strategiesWeekly Market Summary & Free Expert Verified Stock Movement Alerts - newser.com
Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Diamedica Therapeutics Inc-Aktie (DMAC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STAHLBERG JAN | 10% Owner |
Aug 13 '25 |
Buy |
5.91 |
293,601 |
1,734,918 |
7,058,066 |
| STAHLBERG JAN | 10% Owner |
Aug 14 '25 |
Buy |
5.99 |
70,414 |
421,921 |
7,128,480 |
| STAHLBERG JAN | 10% Owner |
Aug 20 '25 |
Buy |
5.86 |
71,107 |
416,495 |
7,207,820 |
| STAHLBERG JAN | 10% Owner |
Aug 26 '25 |
Buy |
6.00 |
59,648 |
357,888 |
7,713,693 |
| STAHLBERG JAN | 10% Owner |
Aug 22 '25 |
Buy |
5.96 |
59,788 |
356,576 |
7,315,780 |
| STAHLBERG JAN | 10% Owner |
Aug 27 '25 |
Buy |
6.00 |
50,772 |
304,632 |
7,764,465 |
| STAHLBERG JAN | 10% Owner |
Aug 21 '25 |
Buy |
5.96 |
48,172 |
287,028 |
7,255,992 |
| STAHLBERG JAN | 10% Owner |
Aug 15 '25 |
Buy |
6.00 |
8,233 |
49,398 |
7,136,713 |
| STAHLBERG JAN | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
1,542,857 |
5,400,000 |
6,764,465 |
| Von Koch Thomas | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
2,857,142 |
9,999,997 |
8,383,577 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):